Metraipolis › archive › dc_876e905a58df

Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance — Europe PMC PMID:41742144

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41742144
DOI: 10.1186/s12890-[numero omesso]-4
License (as archived): solo-consultazione
Archived: 2026-11-05T11:28:02.025Z
SHA-256 of the archived text: aa3238fa00549433beac725e580c585db64d57216f54545c70b6f9f94820844f
Stable URL of this page: https://metraipolis.com/documento/dc_876e905a58df

How to cite

Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance — Europe PMC PMID:41742144 — Europe PMC (en), https://europepmc.org/article/MED/41742144 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_876e905a58df (Metraipolis archive dc_876e905a58df, sha256 aa3238fa00549433beac725e580c585db64d57216f54545c70b6f9f94820844f)

BibTeX

@misc{dc876e905a58df,
  title = {Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance — Europe PMC PMID:41742144},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41742144},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_876e905a58df; sha256 aa3238fa00549433beac725e580c585db64d57216f54545c70b6f9f94820844f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41742144. Agents can read the archived copy with the MCP tool read_document.